Featured news
All news
Showing 20 results
Online platform to check for prostate cancer risk
Cambridge scientists have created an online tool for predicting an individual’s risk of developing prostate cancer, to enable more targeted testing, treatment and early diagnosis.
New hope for kidney cancer treatment
Cambridge researchers have discovered that a drug used to treat lung cancer could potentially help patients with a type of kidney cancer called renal cell carcinoma.
Cancer patients to help trial ‘life saving’ home testing kit
Addenbrooke’s hospital is helping to trial a new home-testing device to check if cancer patients are at risk from a serious side effect of chemotherapy.
Making prostate cancer diagnosis simple, safe and affordable
A new medical device developed at Addenbrooke's hopes to transform the process of diagnosing prostate cancer, making it safer for patients.
Cancer research could have 'far-reaching' implications
The research lead for Cambridge Cancer Research Hospital says new findings to come out of his lab are the most important in three decades.
Genetic test rules out cancer for baby Oliver
A baby who was born with a large tumour on his leg has been spared chemotherapy and surgery, after whole genome sequencing at Addenbrooke’s revealed the lump was harmless.
Patients help to improve radiotherapy services
A new multimedia display at Addenbrooke’s highlights how patients have helped shape radiotherapy treatment.
Launch of UK's first institute for early cancer research
The Early Cancer Institute opens today next door to Addenbrooke's, to help create a world where we can detect cancer early enough to cure it.
MPs pledge support for regional Cancer Research Hospital
Nurse Debbie’s pedal push follows brave cancer journey
An Addenbrooke’s cancer nurse and keen cyclist has come through the most complicated ride of her life.
New regional cancer hospital one step closer
The Cambridge Cancer Research Hospital (CCRH) project has been given the green light by the government’s New Hospital Programme to commence the process that will lead to the appointment of a construction partner.
New clues to treat germ cell tumours
A study by a team from Addenbrooke’s and the Wellcome Sanger Institute has revealed more about the origin of germ cell tumours, usually found in the ovaries and testicles, suggesting new approaches to future treatment.
Home in a day after robotic cancer surgery
A surgical robot at Addenbrooke’s is helping to cure patients with prostate cancer, enabling them to go home less than 24 hours after surgery.
Cambridge teams land £4m to tackle toughest cancers
Two teams of Cambridge scientists – which include experts based at Addenbrooke’s Hospital - are to get a £4m boost to help with the fight against cancer.
Brain cancer care awarded centre of excellence status
Addenbrooke’s hospital is part of six NHS brain cancer centres to be awarded excellence status by the Tessa Jowell Brain Cancer Mission.
Top honours for pioneering Cambridge doctors
Congratulations to Fiona Gilbert and Miles Parkes who are among 8 Cambridge doctors and professors to be elected to the Academy of Medical Sciences.
Richard Gilbertson elected to the Royal Society
Congratulations to Professor Richard Gilbertson, research lead for the new Cambridge Cancer Research Hospital, now recognised for his scientific excellence by the Royal Society.
Big boost for Cambridge 'sponge on a string' cancer test
A multi-million pound trial has been announced to pave the way for the Cytosponge test to become a routine screening programme, to help detect early signs of oesophageal cancer.
Big genetic study reveals new clues to the causes of cancer
Cambridge analysis of more than 12,000 tumours from NHS patients has found DNA evidence of more than 50 new potential causes of cancer.
Landmark NHS testing and treatment for brain cancer
Brain tumour patients at Addenbrooke’s Hospital are the first in the UK to benefit from personalised treatment using the latest innovations in genomics and cancer research.